A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis
Latest Information Update: 24 Aug 2020
At a glance
- Drugs Cetrorelix (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- Sponsors Abbott Healthcare Products; Abbott Laboratories
- 08 Jan 2008 Status changed from in progress to completed.
- 22 Jun 2007 Status changed from recruiting to in progress.
- 10 Jan 2007 Status change